Received Mar 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | L5229 | IM / LA |
Patient received a second dose of Boostrix within the 10-year recommendation time on accident. The patient did not report any signs or symptoms.